Differential expression and pathway enrichment analyses revealed that NOP10- and NHP2-positive PTCs are enriched in pathways critical to cancer biology, including DNA repair, mTORC1 signaling, oxidative phosphorylation, hypoxia, and ROS response. The gene discussed is NHP2; the disease is cancer.